A detailed history of Rtw Investments, LP transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Rtw Investments, LP holds 1,705,960 shares of CGEM stock, worth $20.9 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
1,705,960
Previous 1,052,630 62.07%
Holding current value
$20.9 Million
Previous $18.4 Million 55.56%
% of portfolio
0.46%
Previous 0.31%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$16.03 - $20.86 $10.5 Million - $13.6 Million
653,330 Added 62.07%
1,705,960 $28.6 Million
Q2 2024

Aug 14, 2024

BUY
$15.63 - $29.35 $16.5 Million - $30.9 Million
1,052,630 New
1,052,630 $18.4 Million

Others Institutions Holding CGEM

About Cullinan Oncology, Inc.


  • Ticker CGEM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,612,200
  • Market Cap $560M
  • Description
  • Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...
More about CGEM
Track This Portfolio

Track Rtw Investments, LP Portfolio

Follow Rtw Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rtw Investments, LP with notifications on news.